Clinical Trials Logo

Mild Cognitive Impairment clinical trials

View clinical trials related to Mild Cognitive Impairment.

Filter by:

NCT ID: NCT05229978 Completed - Clinical trials for Mild Cognitive Impairment

Engagement 2.0 Forms of Consent for Data (re-)Use

ENGAGE
Start date: August 17, 2022
Phase:
Study type: Observational

The objective of this qualitative study is to create a better understanding of patients' mental model of health data engagement interfaces and tools (such as Dynamic Consent). The researchers will focus especially on those people who - plausibly - require adjusted communication particularities and interaction modalities due to a cognitive impairment stemming from a neurodegenerative disease. Taking into account the specific characteristics of patients with dementia, the goal of this study is to investigate how to communicate according to patients' personal skills and capabilities and identify both the proper support mechanisms for engagement 2.0 consent as well as feedback mechanisms (return of research results). Through a focus group & interview setup, this study will discern design requirements and propose design recommendations for the (future) development of health data engagement interfaces.

NCT ID: NCT05215717 Completed - Clinical trials for Mild Cognitive Impairment

Hypnosis for Sleep Quality for Individuals With Mild Cognitive Impairment

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

With the long-range goal to identify an efficacious and practical intervention to improve sleep for individuals with MCI, this pilot study will enroll 20 individuals with MCI into either a self-administered hypnosis for sleep program or a sham white noise hypnosis program. Participants will practice hypnosis delivered via audio recording once per day in their own home for 7 weeks. Upon completion of the study, insight will be gained regarding accrual, retention, and feasibility of the intervention and measures. Data from this pilot study is essential to inform and plan a future R01 proposal to determine the efficacy of the self-administered hypnosis intervention to improve sleep quality and duration, as well as other benefits, with individuals with mild cognitive impairment.

NCT ID: NCT05187117 Completed - Depression Clinical Trials

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to test the adapted protocol, CAPABLE Family which builds upon the evidenced based CAPABLE program to address older adults with co-occurring physical disability and mild cognitive impairment or early stage dementia and the older adults' caregivers. It will consist of two phases - an open label pilot and waitlist control trial.

NCT ID: NCT05172661 Completed - Parkinson Disease Clinical Trials

Effects of Physical-Cognitive Training With Different Task Models in Parkinson's Disease With Mild Cognitive Impairment

Start date: November 26, 2021
Phase: N/A
Study type: Interventional

The present study will characterize exercise model effects (integrated model vs. consecutive model) of physical-cognitive exercise on dual-task walking control in Parkinson's disease with mild cognitive impairment.

NCT ID: NCT05172128 Completed - Alzheimer Disease Clinical Trials

Effect of Blueberry Supplementation on Alzheimer's Biomarkers

Start date: February 21, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to study the effects of blueberries on neuronal, glial, and pathology blood biomarkers in Mild Cognitive Impairment (MCI) and to estimate sample size for future confirmatory studies. The blood biomarkers to be measured are Neurofilament light (NfL), glial fibrillary acidic protein (GFAP), Aß40, Aß42, p-tau181, and cytokines, using an ultra-sensitive state-of-the-art immunoassay.

NCT ID: NCT05167045 Completed - Dementia Clinical Trials

A Pilot Study for the Brain Health Support Program

CTU BHSP-P
Start date: November 15, 2021
Phase:
Study type: Observational

Prior studies have shown that programs that focus on promoting brain health and managing lifestyle risks (such as poor diet, obesity, physical inactivity, sleep issues, loneliness) may help in preventing or lowering the risk of dementia. To address this, investigators have developed the CAN-THUMBS UP program to conduct studies that target lifestyle risk and focus on dementia prevention. An online Brain Health Support Program (BHSP) has been developed. The BHSP is an educational program designed to teach about dementia. Before the full BHSP is offered to a large group, we are conducting an initial pilot study to help assess the usability of the program.

NCT ID: NCT05159596 Completed - Alzheimer Disease Clinical Trials

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

Start date: September 20, 2022
Phase: N/A
Study type: Interventional

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

NCT ID: NCT05159583 Completed - Alzheimer Disease Clinical Trials

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in rural homes.

NCT ID: NCT05159557 Completed - Alzheimer Disease Clinical Trials

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Wearables

Start date: August 22, 2022
Phase: N/A
Study type: Interventional

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment by integrating wearable devices (e.g., Apple Watches).

NCT ID: NCT05158595 Completed - Clinical trials for Mild Cognitive Impairment

Exer-game Balance Training on Dementia

Start date: August 15, 2021
Phase: N/A
Study type: Interventional

Age-related cognitive impairment is a wide phenomenon. Mild cognitive impairment is a transitional stage between Dementia and normal cognition.Mild cognitive impairment (MCI) is a syndrome that has been recognized in older adults and it has become a topic of a major focus on clinical care and research. In people with this condition, there are cognitive deficits and these have adverse effects on activities of daily living . These patients cannot recognize their impairment. Mild cognitive impairment is a risk factor for dementia.